Hims vs Mochi Health: GLP-1 Telehealth Provider Comparison
Compare Hims (FDA-approved brand-name) and Mochi Health (compounded). Insurance acceptance, shipping, FDA compliance.
Informational comparison only — not medical advice. Your prescriber decides what's right for you.
FDA Compliance Notice
Hims offers compounded GLP-1 medications. The FDA has issued warning letters to multiple telehealth providers regarding compounded GLP-1 marketing. Discuss FDA-approved alternatives with your provider.
Learn more →We don't currently recommend Mochi Health.
They stay in this comparison because readers search for them, but we don't link to them as partners. See the providers we do recommend →
From
$298/mo
Score
8.0/10
From
$79/mo
Score
6.0/10
Quick answer
Compare Hims (FDA-approved brand-name) and Mochi Health (compounded). Insurance acceptance, shipping, FDA compliance.
- Hims FDA-approved for: See FDA label
- Mochi Health FDA-approved for: See FDA label
- Hims starting price: $298/month
- Mochi Health starting price: $79/month
Quick visual breakdown
Hims wins 0 · Mochi Health wins 2
Hims
0 of 4 wins
Mochi Health
2 of 4 wins
Side-by-side comparison
Neutral comparator. We run no clinic and never sell medication — we earn the same commission whoever you pick, so this ranking is editorial, not pay-to-rank. Methodology · How we make money
Where to start
Partner offers first — we earn a commission from those — then ranked by our editorial score. We earn a commission if you start a consultation through these links — it never changes your price.
Compounded options are not FDA-approved as finished products.
- Sesame Care
Our score 8.2/10
$208/mo
Get from $208/mo $199/mo
Get from $199/mo- Get started
$165/mo
Get from $165/mo
People also compare
Common questions about Hims
Are the medications the same quality?
One provider offers FDA-approved brand-name; the other offers compounded. FDA-approved options have stronger quality oversight.
Further reading (authoritative sources)
- Prescription medications to treat overweight & obesity — NIH — NIDDKGovernment overview of approved weight-management drugs.
- GLP-1 agonists — overview & how they work — NIH — MedlinePlus
- FDA's concerns with unapproved GLP-1 drugs used for weight loss — U.S. FDA
- Medicaid coverage of and spending on GLP-1s — KFFState-by-state coverage data (2026).